Ewa King

1.0k total citations
25 papers, 294 citations indexed

About

Ewa King is a scholar working on Infectious Diseases, Agronomy and Crop Science and Immunology. According to data from OpenAlex, Ewa King has authored 25 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Agronomy and Crop Science and 7 papers in Immunology. Recurrent topics in Ewa King's work include Animal Disease Management and Epidemiology (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and T-cell and Retrovirus Studies (7 papers). Ewa King is often cited by papers focused on Animal Disease Management and Epidemiology (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and T-cell and Retrovirus Studies (7 papers). Ewa King collaborates with scholars based in United States, Canada and Belgium. Ewa King's co-authors include Gregory A. Dekaban, J. Arp, Molly Boyd, Matthew Lozier, Lauren Lewis, Christina Stanley, Colleen Martin, George P. Rice, David J. Waters and T J Palker and has published in prestigious journals such as Journal of Virology, American Journal of Public Health and Virology.

In The Last Decade

Ewa King

24 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa King United States 10 93 80 74 69 69 25 294
A. K. M. Dawlat Khan Bangladesh 7 9 0.1× 36 0.5× 10 0.1× 17 0.2× 63 0.9× 18 269
Amjad Khan Pakistan 8 26 0.3× 18 0.2× 3 0.0× 22 0.3× 15 0.2× 18 299
Maria Helena Lourenço Portugal 10 28 0.3× 6 0.1× 3 0.0× 17 0.2× 19 0.3× 25 519
Kimberly A. Porter United States 11 21 0.2× 8 0.1× 6 0.1× 2 0.0× 131 1.9× 18 324
D. Greenspan United States 6 38 0.4× 17 0.2× 1 0.0× 13 0.2× 58 0.8× 9 514
Larissa Melo Bandeira Brazil 11 113 1.2× 86 1.1× 1 0.0× 72 1.0× 6 0.1× 28 276
Hugo Rázuri Peru 11 9 0.1× 24 0.3× 1 0.0× 6 0.1× 56 0.8× 18 223
Dina Abu Zeid Egypt 8 12 0.1× 68 0.8× 10 0.1× 41 0.6× 13 418
Xiaowei Ma China 11 10 0.1× 32 0.4× 7 0.1× 26 0.4× 22 211

Countries citing papers authored by Ewa King

Since Specialization
Citations

This map shows the geographic impact of Ewa King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa King more than expected).

Fields of papers citing papers by Ewa King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa King. The network helps show where Ewa King may publish in the future.

Co-authorship network of co-authors of Ewa King

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa King. A scholar is included among the top collaborators of Ewa King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa King. Ewa King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gensheimer, Kathleen F., Marc W. Allard, Ruth Timme, et al.. (2024). Genomic Surveillance of Foodborne Pathogens: Advances and Obstacles. Journal of Public Health Management and Practice. 31(3). 351–359. 2 indexed citations
2.
Nuzzo, Jennifer B., et al.. (2024). The United States Needs A Better Testing Playbook For Future Public Health Emergencies. Health Affairs. 43(6). 768–775. 2 indexed citations
4.
Allen, Richard A., et al.. (2022). A pyrosequencing protocol for rapid identification of SARS‐CoV‐2 variants. Journal of Medical Virology. 94(8). 3661–3668. 4 indexed citations
5.
King, Ewa, et al.. (2022). Insights from biosurveillance: non‐fatal opioid overdoses in Rhode Island 2019–21. Addiction. 117(9). 2464–2470. 3 indexed citations
6.
Hogan, Joseph W., Jenny Y. Yang, Philip A. Chan, et al.. (2021). Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats. BMC Infectious Diseases. 21(1). 871–871. 4 indexed citations
7.
Kantor, Rami, Vladimir Novitsky, Mark Howison, et al.. (2021). SARS-CoV-2 Variants in Rhode Island.. PubMed. 104(7). 16–20. 4 indexed citations
8.
Chan, Philip A., Ewa King, Yizhen Xu, et al.. (2021). Seroprevalence of SARS-CoV-2 Antibodies in Rhode Island From a Statewide Random Sample. American Journal of Public Health. 111(4). 700–703. 13 indexed citations
9.
Grisson, Ricky D., Philip A. Chan, Richard C. Huard, et al.. (2020). Validation and performance comparison of three SARS‐CoV‐2 antibody assays. Journal of Medical Virology. 93(2). 916–923. 30 indexed citations
10.
Jiang, Yongwen, et al.. (2018). Rhode Island Unintentional Drug Overdose Death Trends and Ranking - Office of the State Medical Examiners Database.. PubMed. 101(1). 33–36. 3 indexed citations
11.
Buss, Sarah N., Tracy Dalton, Debbie Gibson, et al.. (2017). The Use of a Shared Services Model for Mycobacteriology Testing: Lessons Learned. Public Health Reports. 133(1). 93–99. 2 indexed citations
12.
King, Ewa, et al.. (2016). Non-smoking pregnant women and their fetuses are exposed to environmental tobacco smoke as a result of living in multiunit housing. Journal of Exposure Science & Environmental Epidemiology. 27(5). 465–470. 2 indexed citations
13.
King, Ewa, et al.. (2016). Advancing environmental health surveillance in the US through a national human biomonitoring network. International Journal of Hygiene and Environmental Health. 220(2). 98–102. 4 indexed citations
14.
Lozier, Matthew, Molly Boyd, Christina Stanley, et al.. (2015). Acetyl Fentanyl, a Novel Fentanyl Analog, Causes 14 Overdose Deaths in Rhode Island, March–May 2013. Journal of Medical Toxicology. 11(2). 208–217. 86 indexed citations
15.
Arp, J., Judy Rowe, Susan Perkins, et al.. (1996). A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system. Journal of Virology. 70(11). 7349–7359. 13 indexed citations
16.
Dekaban, Gregory A., Ewa King, J. Arp, T J Palker, & George P. Rice. (1994). Comparative Analysis of the Antibody Response to the HTLV‐I gag and env Proteins in HTLV‐I Asymptomatic Carriers and HAM/TSP Patients: an Isotype and Subclass Analysis. Scandinavian Journal of Immunology. 40(2). 171–180. 8 indexed citations
17.
Dekaban, Gregory A., Joël Oger, Dean Foti, et al.. (1994). HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis. Clinical and Diagnostic Virology. 2(2). 67–78. 12 indexed citations
18.
Arp, J., Christopher M. Ford, T J Palker, Ewa King, & Gregory A. Dekaban. (1993). Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system. Journal of General Virology. 74(2). 211–222. 15 indexed citations
19.
Dekaban, Gregory A., Ewa King, David J. Waters, & George P. Rice. (1992). Nucleotide Sequence Analysis of an HTLV-I Isolate from a Chilean Patient with HAM/TSP. AIDS Research and Human Retroviruses. 8(7). 1201–1207. 21 indexed citations
20.
Ford, Christopher M., J. Arp, T J Palker, Ewa King, & Gregory A. Dekaban. (1992). Characterization of the antibody response to three different versions of the HTLV-I envelope protein expressed by recombinant vaccinia viruses: Induction of neutralizing antibody. Virology. 191(1). 448–453. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026